Tom Knight, founder and CEO of Invistics, discusses how the COVID-19 pandemic has highlighted the need for better solutions for drug diversion, where healthcare employees commit medication theft, within their healthcare organizations and how technology can help resolve the issue.
On this week's episode of Data Book, Chief Healthcare Executive™ spoke with Tom Knight, founder and CEO of Invistics, to discuss the dangers of drug diversion in healthcare institutions and how machine learning technology can help solve this issue and prevent it in the future. We also discussed how the COVID-19 pandemic has impacted the frequency at which drug diversion happens and how that’s expected to change as the pandemic comes to an end.
Patients do better, save money by getting glucose monitoring devices as medical benefit, study finds
October 2nd 2024Researchers found patients had better outcomes and lower costs by obtaining the devices through a medical benefit over a pharmacy. Arti Masturzo, chief medical officer at CCS, talks about the study and implications for patients.